The Enzyme Technology Alliance (ETA) is an agile, multidisciplinary consortium designed to bridge the gap between early-stage discovery and industrial-scale implementation. We provide a seamless, end-to-end framework that allows researchers and process developers to tackle the most complex biocatalytic challenges without the friction of traditional large-scale collaborations.
Rather than offering fragmented services, the ETA functions as a unified pipeline where our members apply their specialized technical proficiencies toward targeted stages of the project lifecycle, acting as interlocking pieces of a puzzle. Allozymes contributes their expertise in ultra-high-throughput engineering and microfluidics, while Aminoverse focuses on enzyme engineering and the development of specialized biocatalyst panels. Bioprodict provides support through AI-driven engineering platforms and advanced bioinformatics, while Candidum is dedicated to accelerating discovery and generating diverse libraries. Furthermore, Chiral Vision applies their knowledge in enzyme immobilization and precision chiral synthesis, Enzymicals handles industrial biocatalysis and systematic process development, and SpinChem drives process intensification and optimization using rotating bed reactor technology.
The ETA is built on a non-exclusive, flexible structure designed to maintain the independence of our partners while maximizing project velocity. A designated lead partner acts as your primary point of contact, minimizing administrative overhead and ensuring that scientific communication remains direct and efficient. Our flexible model allows for the precise alignment of solutions with your specific research requirements, avoiding rigid, pre-set structures. Finally, we prioritize the integrity of your research; clients retain full control over the flow of confidential data, supported by clear, transparent protocols for IP transfer throughout the project duration.
By combining deep technical expertise with a collaborative, scientist-first approach, the ETA provides the infrastructure necessary to develop superior proteins and transition complex chemo-enzymatic processes from the bench to the plant.